Welcome to Take 10, where the topics are focused, the conversations are quick, and the insights are real. Each month, we bring you thoughtful exchanges with patient advocates, researchers, innovators, industry experts, care specialists, and more – all to illuminate the most significant developments in oncology and the people who are redefining life with cancer.
All content for Take 10 is the property of Johnson & Johnson and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Take 10, where the topics are focused, the conversations are quick, and the insights are real. Each month, we bring you thoughtful exchanges with patient advocates, researchers, innovators, industry experts, care specialists, and more – all to illuminate the most significant developments in oncology and the people who are redefining life with cancer.
Episode 2 – Imran Khan, Vice President, J&J US Hematology Medical Affairs
Take 10
10 minutes 45 seconds
1 year ago
Episode 2 – Imran Khan, Vice President, J&J US Hematology Medical Affairs
In our second episode, Tyrone speaks with Imran Khan, Vice President of US Hematology Medical Affairs, about the historic disease landscape of multiple myeloma. The pair will touch on recent advancements that have redefined care for patients as well as the work Janssen is doing to support patients and address critical issues within multiple myeloma, resulting in improved patient outcomes and earlier detection rates.
Take 10
Welcome to Take 10, where the topics are focused, the conversations are quick, and the insights are real. Each month, we bring you thoughtful exchanges with patient advocates, researchers, innovators, industry experts, care specialists, and more – all to illuminate the most significant developments in oncology and the people who are redefining life with cancer.
